STING1 and small cell lung carcinoma: Recent studies on SCLC showed that the effect of the combination therapy with DDR inhibitors was correlated with the activity of DNA repair response in patients and that DDR inhibitors could trigger STING‐IFN activation in SCLC models.20, 22